Invacare Corp. Upgraded to Neutral by Zacks (IVC)
Invacare Corp. (NYSE:IVC) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Tuesday, StockRatingsNetwork.com reports. The firm currently has a $17.00 price target on the stock. Zacks‘ price objective indicates a potential upside of 2.41% from the company’s current price.
Shares of Invacare Corp. (NYSE:IVC) traded up 0.36% on Tuesday, hitting $16.60. 119,595 shares of the company’s stock traded hands. Invacare Corp. has a 1-year low of $10.26 and a 1-year high of $18.27. The stock’s 50-day moving average is $16.27 and its 200-day moving average is $14.8. The company has a market cap of $531.2 million and a price-to-earnings ratio of 28.67.
Invacare Corp. (NYSE:IVC) last announced its earnings results on Thursday, July 25th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.07. The company had revenue of $351.80 million for the quarter, compared to the consensus estimate of $320.00 million. During the same quarter last year, the company posted $0.30 earnings per share. Invacare Corp.’s revenue was down 5.6% compared to the same quarter last year.
Other equities research analysts have also recently issued reports about the stock. Analysts at CJS Securities initiated coverage on shares of Invacare Corp. in a research note to investors on Tuesday, September 24th. They set an “outperform” rating on the stock. Analysts at TheStreet upgraded shares of Invacare Corp. from a “sell” rating to a “hold” rating in a research note to investors on Monday, July 15th.
Invacare Corporation (NYSE:IVC) is the manufacturer and distributor of medical equipment and supplies used in home.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.